Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
J Perinat Med ; 49(6): 740-747, 2021 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-33735952

RESUMEN

OBJECTIVES: To determine the causes of fetal death among the stillbirths using two classification systems from 22 weeks of gestation in a period of three years in high-risk pregnancies. This is a retrospective observational study. METHODS: The National Institute of Perinatal Health in Mexico City is a Level 3 care referral center attending high-risk pregnancies from throughout the country. The population consisted of patients with fetal death during a three-year period. Between January 2016 and December 2018, all stillbirths were examined in the Pathology Department by a pathologist and a medical geneticist. Stillbirth was defined as a fetal death occurring after 22 weeks of gestation. RESULTS: Main outcome measures: Causal analysis of fetal death using the International Statistical Classification of Disease and Related Health Problems-Perinatal Mortality (ICD-PM) and initial causes of fetal death (INCODE) classification systems. A total of 297 stillborn neonates were studied. The distribution of gestational age in antepartum stillbirths (55.2%) showed a bimodal curve, 36% occurred between 24 and 27 weeks and 32% between 32 and 36 weeks. In comparison, the majority (86%) of intrapartum deaths (44.8%) were less than 28 weeks of gestation. Of the 273 women enrolled, 93 (34%) consented to a complete fetal autopsy. The INCODE system showed a present cause in 42%, a possible cause in 54% and a probable cause in 93% of patients. CONCLUSIONS: The principal causes of antepartum death were fetal abnormalities and pathologic placental conditions and the principal causes of intrapartum death were complications of pregnancy which caused a premature labor and infections.


Asunto(s)
Anomalías Congénitas , Muerte Fetal/etiología , Enfermedades Placentarias , Complicaciones del Embarazo , Mortinato/epidemiología , Adulto , Causalidad , Causas de Muerte , Anomalías Congénitas/diagnóstico , Anomalías Congénitas/epidemiología , Femenino , Mortalidad Fetal , Edad Gestacional , Humanos , México/epidemiología , Enfermedades Placentarias/diagnóstico , Enfermedades Placentarias/epidemiología , Embarazo , Complicaciones del Embarazo/diagnóstico , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Embarazo de Alto Riesgo
2.
J Infect Dis ; 220(2): 195-202, 2019 06 19.
Artículo en Inglés | MEDLINE | ID: mdl-30788508

RESUMEN

BACKGROUND: In 2015, the laboratory at the Ebola treatment center in Coyah, Guinea, confirmed Ebola virus disease (EVD) in 286 patients. The cycle threshold (Ct) of an Ebola virus-specific reverse transcription-polymerase chain reaction assay and 13 blood chemistry parameters were measured on admission and during hospitalization. Favipiravir treatment was offered to patients with EVD on a compassionate-use basis. METHODS: To reduce biases in the raw field data, we carefully selected 163 of 286 patients with EVD for a retrospective study to assess associations between potential risk factors, alterations in blood chemistry findings, favipiravir treatment, and outcome. RESULTS: The case-fatality rate in favipiravir-treated patients was lower than in untreated patients (42.5% [31 of 73] vs 57.8% [52 of 90]; P = .053 by univariate analysis). In multivariate regression analysis, a higher Ct and a younger age were associated with survival (P < .001), while favipiravir treatment showed no statistically significant effect (P = .11). However, Kaplan-Meier analysis indicated a longer survival time in the favipiravir-treated group (P = .015). The study also showed characteristic changes in blood chemistry findings in patients who died, compared with survivors. CONCLUSIONS: Consistent with the JIKI trial, this retrospective study revealed a trend toward improved survival in favipiravir- treated patients; however, the effect of treatment was not statistically significant, except for its influence on survival time.


Asunto(s)
Amidas/uso terapéutico , Antivirales/uso terapéutico , Ebolavirus/efectos de los fármacos , Fiebre Hemorrágica Ebola/tratamiento farmacológico , Pirazinas/uso terapéutico , Adolescente , Adulto , Niño , Preescolar , Ensayos de Uso Compasivo/métodos , Femenino , Guinea , Fiebre Hemorrágica Ebola/virología , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Carga Viral/efectos de los fármacos , Adulto Joven
3.
Methods Mol Biol ; 2831: 283-299, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39134857

RESUMEN

Mosaic Analysis with Double Markers (MADM) is a powerful genetic method typically used for lineage tracing and to disentangle cell autonomous and tissue-wide roles of candidate genes with single cell resolution. Given the relatively sparse labeling, depending on which of the 19 MADM chromosomes one chooses, the MADM approach represents the perfect opportunity for cell morphology analysis. Various MADM studies include reports of morphological anomalies and phenotypes in the central nervous system (CNS). MADM for any candidate gene can easily incorporate morphological analysis within the experimental workflow. Here, we describe the methods of morphological cell analysis which we developed in the course of diverse recent MADM studies. This chapter will specifically focus on methods to quantify aspects of the morphology of neurons and astrocytes within the CNS, but these methods can broadly be applied to any MADM-labeled cells throughout the entire organism. We will cover two analyses-soma volume and dendrite characterization-of physical characteristics of pyramidal neurons in the somatosensory cortex, and two analyses-volume and Sholl analysis-of astrocyte morphology.


Asunto(s)
Astrocitos , Neuroglía , Neuronas , Animales , Neuronas/citología , Neuronas/metabolismo , Astrocitos/citología , Astrocitos/metabolismo , Neuroglía/citología , Neuroglía/metabolismo , Ratones , Mosaicismo , Biomarcadores , Dendritas/metabolismo , Corteza Somatosensorial/citología
4.
Stem Cell Reports ; 17(10): 2220-2238, 2022 10 11.
Artículo en Inglés | MEDLINE | ID: mdl-36179695

RESUMEN

Telencephalic organoids generated from human pluripotent stem cells (hPSCs) are a promising system for studying the distinct features of the developing human brain and the underlying causes of many neurological disorders. While organoid technology is steadily advancing, many challenges remain, including potential batch-to-batch and cell-line-to-cell-line variability, and structural inconsistency. Here, we demonstrate that a major contributor to cortical organoid quality is the way hPSCs are maintained prior to differentiation. Optimal results were achieved using particular fibroblast-feeder-supported hPSCs rather than feeder-independent cells, differences that were reflected in their transcriptomic states at the outset. Feeder-supported hPSCs displayed activation of diverse transforming growth factor ß (TGFß) superfamily signaling pathways and increased expression of genes connected to naive pluripotency. We further identified combinations of TGFß-related growth factors that are necessary and together sufficient to impart broad telencephalic organoid competency to feeder-free hPSCs and enhance the formation of well-structured brain tissues suitable for disease modeling.


Asunto(s)
Organoides , Células Madre Pluripotentes , Diferenciación Celular/fisiología , Humanos , Organoides/metabolismo , Células Madre Pluripotentes/metabolismo , Telencéfalo/metabolismo , Factor de Crecimiento Transformador beta/metabolismo
5.
Nat Neurosci ; 24(10): 1488-1500, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34426698

RESUMEN

Brain organoids represent a powerful tool for studying human neurological diseases, particularly those that affect brain growth and structure. However, many diseases manifest with clear evidence of physiological and network abnormality in the absence of anatomical changes, raising the question of whether organoids possess sufficient neural network complexity to model these conditions. Here, we explore the network-level functions of brain organoids using calcium sensor imaging and extracellular recording approaches that together reveal the existence of complex network dynamics reminiscent of intact brain preparations. We demonstrate highly abnormal and epileptiform-like activity in organoids derived from induced pluripotent stem cells from individuals with Rett syndrome, accompanied by transcriptomic differences revealed by single-cell analyses. We also rescue key physiological activities with an unconventional neuroregulatory drug, pifithrin-α. Together, these findings provide an essential foundation for the utilization of brain organoids to study intact and disordered human brain network formation and illustrate their utility in therapeutic discovery.


Asunto(s)
Encéfalo/fisiopatología , Epilepsia/fisiopatología , Neuronas , Adulto , Benzotiazoles/farmacología , Encéfalo/crecimiento & desarrollo , Señalización del Calcio , Preescolar , Epilepsia/diagnóstico por imagen , Femenino , Humanos , Células Madre Pluripotentes Inducidas , Proteína 2 de Unión a Metil-CpG/genética , Red Nerviosa/fisiopatología , Neurogénesis/genética , Neuroimagen , Síndrome de Rett/diagnóstico por imagen , Síndrome de Rett/fisiopatología , Análisis de la Célula Individual , Sinapsis , Tolueno/análogos & derivados , Tolueno/farmacología , Transcriptoma
6.
Microbiologyopen ; 8(4): e00692, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-29987921

RESUMEN

Carbapenems are ß-lactam antibiotics used in healthcare settings as last resort drugs to treat infections caused by antibiotic-resistant bacteria. Carbapenem-resistant bacteria are increasingly being isolated from healthcare facilities; however, little is known about their distribution or prevalence in the environment, especially in the United States, where their distribution in water environments from the West Coast has not been studied before. The aim of this study was to determine the prevalence of carbapenem-resistant bacteria and carbapenemase genes in water bodies from the Los Angeles area (California, USA). All samples that were analyzed contained carbapenem-resistant bacteria with a frequency of between 0.1 and 324 carbapenem-resistant cfu per 100 mls of water. We identified 76 carbapenem-resistant or -intermediate isolates, most of which were also resistant to noncarbapenem antibiotics, as different strains of Enterobacter asburiae, Aeromonas veronii, Cupriavidus gilardii, Pseudomonas, and Stenotrophomonas species. Of them, 52 isolates were carbapenemase-producers. Furthermore, PCR and sequence analysis to identify the carbapenemase gene of these carbapenemase-producing isolates revealed that all Enterobacter asburiae isolates had a blaIMI-2 gene 100% identical to the reference sequence, and all Stenotrophomonas maltophlia isolates had a blaL1 gene 83%-99% identical to the reference blaL1 . Our findings indicate that water environments in Southern California are an important reservoir of bacteria-resistant to carbapenems and other antibiotics, including bacteria carrying intrinsic and acquired carbapenemase genes.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Carbapenémicos/farmacología , Farmacorresistencia Bacteriana , Agua Dulce/microbiología , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Los Angeles , Pruebas de Sensibilidad Microbiana , Prevalencia , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
7.
PLoS Negl Trop Dis ; 11(5): e0005645, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28558022

RESUMEN

BACKGROUND: Human Ebola infection is characterized by a paralysis of the immune system. A signature of αß T cells in fatal Ebola infection has been recently proposed, while the involvement of innate immune cells in the protection/pathogenesis of Ebola infection is unknown. Aim of this study was to analyze γδ T and NK cells in patients from the Ebola outbreak of 2014-2015 occurred in West Africa, and to assess their association with the clinical outcome. METHODOLOGY/PRINCIPAL FINDINGS: Nineteen Ebola-infected patients were enrolled at the time of admission to the Ebola Treatment Centre in Guinea. Patients were divided in two groups on the basis of the clinical outcome. The analysis was performed by using multiparametric flow cytometry established by the European Mobile Laboratory in the field. A low frequency of Vδ2 T-cells was observed during Ebola infection, independently from the clinical outcome. Moreover, Vδ2 T-cells from Ebola patients massively expressed CD95 apoptotic marker, suggesting the involvement of apoptotic mechanisms in Vδ2 T-cell loss. Interestingly, Vδ2 T-cells from survivors expressed an effector phenotype and presented a lower expression of the CTLA-4 exhaustion marker than fatalities, suggesting a role of effector Vδ2 T-cells in the protection. Furthermore, patients with fatal Ebola infection were characterized by a lower NK cell frequency than patients with non fatal infection. In particular, both CD56bright and CD56dim NK frequency were very low both in fatal and non fatal infections, while a higher frequency of CD56neg NK cells was associated to non-fatal infections. Finally, NK activation and expression of NKp46 and CD158a were independent from clinical outcome. CONCLUSIONS/SIGNIFICANCES: Altogether, the data suggest that both effector Vδ2 T-cells and NK cells may play a role in the complex network of protective response to EBOV infection. Further studies are required to characterize the protective effector functions of Vδ2 and NK cells.


Asunto(s)
Fiebre Hemorrágica Ebola/inmunología , Fiebre Hemorrágica Ebola/mortalidad , Células Asesinas Naturales/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Subgrupos de Linfocitos T/inmunología , Biomarcadores/metabolismo , Antígeno CD56/metabolismo , Antígeno CTLA-4/metabolismo , Bases de Datos Factuales , Ebolavirus , Femenino , Citometría de Flujo , Guinea/epidemiología , Humanos , Activación de Linfocitos/inmunología , Masculino , Receptor 1 Gatillante de la Citotoxidad Natural/metabolismo , Receptores KIR2DL1/metabolismo , Carga Viral , Receptor fas/metabolismo
8.
Educ. méd. salud ; 20(3): 375-81, 1986. tab
Artículo en Español | LILACS | ID: lil-37708

RESUMEN

Desde 1959, Cuba triplicó el número de instalaciones médicas, equipo y servicios de salud que atienden a la población. En ese contexto, los recursos humanos en salud son adecuados para lograr los objetivos del plan de salud pública. La disponibilidad de recursos humanos en 1985 fue del 100% (247,2 integrantes del personal de salud por 10000 habitantes). La distribución geográfica presenta el desequilibrio urbano-rural que es habitual, pero que tiende a mejorar; se señala el caso de La Habana que en 1959 concentraba el 63% de los médicos y que actualmente concentra el 29,9%. Debido a que los recursos humanos en salud en Cuba son suficientes y de nivel adecuado a las necesidades, las recomendaciones tienden a mejorar algunos aspectos como: la asimilación de la tecnología moderna, dar mayor importancia a la prevención y a la atención primaria y prover un médico por 120 familias o 600 personas a través de la creación de la especialidad de la medicina general integral


Asunto(s)
Humanos , Fuerza Laboral en Salud , Cuba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA